look news india
Covishield maker AstraZeneca (AZN Ltd) will withdraw its Covid-19 vaccine worldwide. On Tuesday (May 7, 2024), the British-Swedish multinational pharmaceutical and biotechnology company informed that it has started the process of withdrawing the vaccine. A report by news agency Reuters also quoted the company as saying that it had to take this step due to decline in demand.
AZN Ltd also said it would withdraw the marketing authorization of the Vaxzevria vaccine in Europe. According to the company's statement, “Many Covid-19 vaccines have been developed after the Corona epidemic. In such a situation, updated vaccines are also available in the markets. AstraZeneca also said demand for its Vaxvaria vaccine had fallen because of this. This is why it is no longer manufactured or supplied.
The move by the COVID-19 vaccine maker comes days after AstraZeneca acknowledged for the first time in court documents that its vaccine, developed in partnership with the University of Oxford, could pose a risk of rare and serious blood clots. Is
The Oxford-AstraZeneca Covid vaccine, sold as Covishield in India and Vaxjavria in Europe, is a viral vector vaccine, developed using a modified chimpanzee adenovirus. Covishield, manufactured and marketed in Hindustan in partnership with the Serum Institute of India (SII), was widely administered in India to about 90% of the Indian population.